PMC3389951_01
Patient K.A.: CT scan and PET-CT with gallium-68 labeled somatostatin analogues on 8 October 2008: no radiological changes in the left upper abdomen with physiological radiotracer uptake in the liver, intestine and kidney.
poljradiol-77-1-68-g001AB.jpg
PMC3389951_01_poljradiol-77-1-68-g001AB.jpg
f1A-poljradiol-77-1-68
May 2009, showed that the size of the lesions at the site of the resected spleen increased. Moreover, PET examination showed two foci of radiotracer uptake within those lesions, not present in the previous examination (Figure 1C,D).
PMC3389951_02
Patient K.A.: CT scan and PET-CT with gallium-68 labeled somatostatin analogues on 25 May 2009: two oval masses in the left upper abdomen, not vizualised before, initially interpreted as cancer localizations.
poljradiol-77-1-68-g001CD.jpg
PMC3389951_02_poljradiol-77-1-68-g001CD.jpg
f1C-poljradiol-77-1-68
Our institute performed PET examination with 18F-FDG on 25 January 2011, which showed a trace uptake within the round lesion subdiaphragmatically, on the left side (SUV max 1.05) (Figure 2A).
PMC3389951_03
Scintigrafic SPECT scan of the same patient performed in November 24,2009 with nanocolloid radiolabelled with 99mTc, with focal uptake of the masses in left upper abdomen, typical for accessory spleens.
poljradiol-77-1-68-g001E.jpg
PMC3389951_03_poljradiol-77-1-68-g001E.jpg
f1E-poljradiol-77-1-68